Unlearn is a pioneering AI company with a product-driven focus, dedicated to transforming medicine by eliminating trial and error. Our Platform harnesses the power of digital twins—advanced computational models of patients—to empower pharmaceutical and biotech companies to overcome critical challenges in clinical development. For more information, go to https://www.unlearn.ai/

Evidation connects directly with millions of individuals to measure, understand, and improve health in everyday life so that everyday health insights can become extraordinary innovations. Evidation helps customers harness longitudinal real-world data, so they can accelerate recruitment, enhance medical evidence and more successfully engage and activate patients. To learn more, visit https://evidation.com/

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. To learn more, please visit www.astrazeneca.com

Altus is focused on developing value-added medicines in the central nervous system (CNS) space. We leverage a range of patented drug delivery technologies to formulate cost-effective and quick-to-market solutions designed to address unmet patient needs in growing therapeutic areas. We’re seeking co-development partners for in-licensing opportunities across the globe. To learn more, please visit www.altusformulation.com

As a purpose-fueled drug delivery CDMO, we leverage our specialist injectable, inhalation and dermal expertise to accelerate your product’s journey and make tomorrow’s possibilities a reality.

From development to commercial manufacturing and beyond, amplify your product’s impact with our exceptional-by-design CDMO solutions.

Latest News

Our Bridgeton facility has over 155,000 sq. ft. of dedicated aseptic operations space, including state-of-the-art laboratories and formulation suites, alongside almost 11,000 sq. ft. of fill suites to ensure the highest levels of quality and patient safety.

We are a leader in next-generation vaccine and biologics delivery technology. With one core platform, we have multiple drug delivery devices for HCP and self-administration. Pharma Latch Hollow is an innovative solution that utilises hollow microneedles for direct intradermal administration delivered by HCP’s. The technology creates a new injection usability paradigm that is highly cost effective and scalable. For more information visit: www.pharmalatch.com

TEST

Re-Vana Therapeutics is a Transformative Ocular Therapeutics company, developing Sustained Release 6 Months+ Biologics with our proprietary biodegradable photo crosslinked technologies. To learn more, please visit https://www.revanatx.com/

SynerGene seeks to improve patient outcomes through novel nanomedicines that enhance the delivery of therapeutic molecules via a nanocomplex that not only “homes” to cancer cells but also delivers diverse payloads across the blood-brain barrier. SynerGene’s SGT-53 is now in a Phase II trial for patients with advanced pancreatic cancers. For more information visit synergeneapi.com

KeborMed delivers the industry’s most advanced, regulatory compliant connectivity platform for MedTech and Pharma applications. Our plug-n-play solution transforms data management, bypassing traditional custom development hurdles. This empowers businesses to expedite high-quality drug discovery and delivery, significantly enhancing patient care and providing a competitive edge in the rapidly evolving healthcare landscape. To learn more, please visit https://kebormed.com/

3P innovation is a UK-based custom automation company supporting pharma and medical device businesses to develop new products, devices and novel production processes. 3P innovation specialises in aseptic processing and powder/liquid filling technologies, designing and building scalable GMP production solutions, from lab-scale/bench-top machines through to commercial-scale lines. To learn more, please visit www.3pinnovation.com